Trial result ·
Potassium-increasing regimens in patients at high risk of ventricular arrhythmias: a prespecified observational analysis of the randomized POTCAST trial.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This study used data from the POTCAST trial of 1200 people. All had a heart device called an ICD. They were at high risk of heart rhythm problems. The trial tried to raise blood potassium to the high end of normal. Here, the team looked at 600 people in the control group. They also looked at 572 people whose potassium was raised. Those people got an MRA drug, potassium supplements, or both. The main outcome joined rhythm events, device treatment, hospital stays and deaths.
What they found
After 6 months, blood potassium rose in each treated group. The MRA group started at 4.12 mmol/L and reached 4.27. The supplement group started at 3.99 mmol/L and reached 4.24. The group on both started at 3.98 mmol/L and reached 4.34. The main outcome hit 175 people in the control group. It hit 16, 31 and 72 people in the treated groups. The treated groups did not clearly differ from each other. Low potassium was less common with each treatment than in controls. High potassium was more common with supplements or both than in controls. Safety did not clearly differ between the treated groups.
What it means for patients
Each way of treatment raised blood potassium. Each was linked to fewer main outcome events than in controls. The authors call these lower rates numerical only. No way of raising potassium stood out from the others. This held for both the main outcome and safety.
Why it is not certain yet
This was an observational look inside a randomised trial. People were not put into each treatment way at random. So other factors may explain some of the results. Only people who finished raising their potassium were included. The lower rates versus controls were not shown as clear differences.
Source
Potassium-increasing regimens in patients at high risk of ventricular arrhythmias: a prespecified observational analysis of the randomized POTCAST trial.
PubMed · PMID 42834820We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Ventricular tachycardia publications